Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395:795–808.
Connelly PJ, Casey H, Montezano AC, Touyz RM, Delles C. Sex steroids receptors, hypertension, and vascular ageing. J Hum Hypertens. 2021. https://doi.org/10.1038/s41371-021-00576-7.
• Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396:565–82. An excellent review of the concepts of sex and gender as modifiers of health and disease.
Wei YC, George NI, Chang CW, et al. Assessing sex differences in the risk of cardiovascular disease and mortality per increment in systolic blood pressure: a systematic review and meta-analysis of follow-up studies in the United States. 2017;12:e0170218.
Lam CSP, Arnott C, Beale AL, et al. Sex differences in heart failure. Eur Heart J. 2019;40:3859–68c.
Satoh M, Hirose T, Nakayama S, et al. Blood pressure and chronic kidney disease stratified by gender and the use of antihypertensive drugs. J Am Heart Assoc. 2020;9. https://doi.org/10.1161/JAHA.119.015592.
Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334–57.
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-248.
Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics—2021 update. Circulation. 2021;143:E254-743.
Leung AA, Williams JVA, McAlister FA, Campbell NRC, Padwal RS. Worsening hypertension awareness, treatment, and control rates in canadian women between 2007 and 2017. Can J Cardiol. 2020;36:732–9.
Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China. Circulation. 2018;137:2344–56.
Islam JY, Zaman MM, Ahmed JU, Choudhury SR, Khan H, Zissan T. Sex differences in prevalence and determinants of hypertension among adults: a cross-sectional survey of one rural village in Bangladesh. BMJ Open. 2020;10:e037546.
•• Neufcourt L, Deguen S, Bayat S, Zins M, Grimaud O. Gender differences in the association between socioeconomic status and hypertension in France: a cross-sectional analysis of the CONSTANCES cohort. PLoS One. 2020;15:1–14. In this cross-sectional analysis of a large sample of adults, socioeconomic status, and in particular education, was associated more strongly with hypertension prevalence in women compared to men.
Dasgupta K, O’Loughlin J, Chen S, et al. Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort. Circulation. 2006;114:2663–70.
Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017–2018. NCHS Data Brief. 2020;364:1–8.
Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020;141:E139-596.
•• Ji H, Kim A, Ebinger JE, et al. Sex differences in blood pressure trajectories over the life course. JAMA Cardiol. 2020;5:255–62. A sex-specific analyses demonstrating that blood pressure increases more rapidly in females than males from the third decade of life.
Connelly P, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The importance of gender to understand sex differences in cardiovascular disease. Can J Cardiol. 2021;37:699–710.
Stuart JJ, Tanz LJ, Missmer SA, et al. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study. Ann Intern Med. 2018;169:224–32.
• Garovic VD, White WM, Vaughan L, et al. Incidence and long-term outcomes of hypertensive disorders of pregnancy. J Am Coll Cardiol. 2020;75:2323–34. This study demonstrates that a history of hypertension in pregnancy significantly increases in risk for future chronic conditions and multimorbidity.
Chidambaram M, Duncan JA, Lai VS, et al. Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol. 2002;13:446–52.
Lu KT, Keen HL, Weatherford ET, Sequeira-Lopez MLS, Gomez RA, Sigmund CD. Estrogen receptor α is required for maintaining baseline renin expression. Hypertension. 2016;67:992–9.
Santos RAS, Sampaio WO, Alzamora AC, et al. The ACE2/angiotensin-(1–7)/Mas axis of the renin-angiotensin system: focus on angiotensin-(1–7). Physiol Rev. 2018;98:505–53.
Costa-Fraga FP, Goncalves GK, Souza-Neto FP, et al. Age-related changes in vascular responses to angiotensin-(1–7) in female mice. J Renin-Angiotensin-Aldosterone Syst. 2018;19. https://doi.org/10.1177/1470320318789332.
Mirabito KM, Hilliard LM, Head GA, Widdop RE, Denton KM. Pressor responsiveness to angiotensin II in female mice is enhanced with age: role of the angiotensin type 2 receptor. Biol Sex Differ. 2014;5. https://doi.org/10.1186/s13293-014-0013-7.
Brown RD, Hilliard LM, Head GA, Jones ES, Widdop RE, Denton KM. Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II. Hypertension. 2012;59:129–35.
Barsha G, Mirabito Colafella KM, Walton SL, et al. In aged females, the enhanced pressor response to angiotensin II is attenuated by estrogen replacement via an angiotensin type 2 receptor-mediated mechanism. Hypertension. 2021;78:128–37.
Manosroi W, Tan JW, Rariy CM, et al. The association of estrogen receptor-β gene variation with salt-sensitive blood pressure. J Clin Endocrinol Metab. 2017;102:4124–35.
Chen YY, Zhang P, Zhou XM, et al. Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites. J Clin Pharm Ther. 2018;43:189–95.
Dalmasso C, Patil CN, Cardozo LLY, Romero DG, Maranon RO. Cardiovascular and metabolic consequences of testosterone supplements in young and old male spontaneously hypertensive rats: implications for testosterone supplements in men. J Am Heart Assoc. 2017;6:e007074.
Mishra JS, More AS, Gopalakrishnan K, Kumar S. Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats. Biol Reprod. 2019;100:139–48.
Yusuf PS, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364:937–52.
Albrektsen G, Heuch I, Løchen ML, et al. Risk of incident myocardial infarction by gender: interactions with serum lipids, blood pressure and smoking. The Tromsø Study 1979–2012. Atherosclerosis. 2017;261:52–9.
Millett ERCC, Peters SAEE, Woodward M. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ. 2018;363.
Lee H, Yano Y, Cho SMJ, et al. Cardiovascular risk of isolated systolic or diastolic hypertension in young adults. Circulation. 2020;141:1778–86.
Kringeland E, Tell GS, Midtbø H, Igland J, Haugsgjerd TR, Gerdts E. Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study. Eur J Prev Cardiol. 2021;zwab068. https://doi.org/10.1093/eurjpc/zwab068.
Izzo R, Losi MA, Stabile E, et al. Development of left ventricular hypertrophy in treated hypertensive outpatients. Hypertension. 2017;69:136–42.
Stolfo D, Uijl A, Vedin O, et al. Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, and prognostic and therapeutic implications. JACC Hear Fail. 2019;7:505–15.
Madsen TE, Howard G, Kleindorfer DO, et al. Sex differences in hypertension and stroke risk in the REGARDS study. Hypertension. 2019;74:749–55.
Ji H, Niiranen TJ, Rader F, et al. Sex differences in blood pressure associations with cardiovascular outcomes. Circulation. 2021;143:761–3.
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755–62.
Kjeldsen SE, Kolloch RE, Leonetti G, et al. Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. J Hypertens. 2000;18. https://doi.org/10.1097/00004872-200018050-00017.
Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–85.
Lewis C, Fine L, Beddhu S, et al. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med. 2021;384:1921–30.
Foy CG, Lovato LC, Vitolins MZ, et al. Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial. J Hypertens. 2018;36:904–15.
Ochoa-Jimenez R, Viquez-Beita K, Daluwatte C, Zusterzeel R. Sex differences of patients with systemic hypertension (from the analysis of the Systolic Blood Pressure Intervention Trial [SPRINT]). Am J Cardiol. 2018;122:985–93.
Wenger NK, Ferdinand KC, Bairey Merz CN, Walsh MN, Gulati M, Pepine CJ. Women, hypertension, and the Systolic Blood Pressure Intervention Trial. Am J Med. 2016;129:1030–6.
Pana TA, Luben RN, Mamas MA, et al. Long term prognostic impact of sex-specific longitudinal changes in blood pressure. The EPIC-Norfolk Prospective Population Cohort Study. Eur J Prev Cardiol. 2021;44. https://doi.org/10.1093/eurjpc/zwab104.
Zhao M, Woodward M, Vaartjes I, et al. Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9. https://doi.org/10.1161/JAHA.119.014742.
Osude N, Durazo-Arvizu R, Markossian T, et al. Age and sex disparities in hypertension control: the multi-ethnic study of atherosclerosis (MESA). Am J Prev Cardiol. 2021;8:100230.
Boynton RE, Todd RL. Blood pressure readings of 75,258 university students. Arch Intern Med. 1947;80:454–62.